-

Mercury Systems, Inc. (MRCY) Investor Notice: Robbins LLP Reminds Shareholders of Class Action Filed Against Mercury Systems, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Mercury Systems, Inc. (NASDAQ: MRCY) common stock between December 7, 2020 and June 23, 2023. Mercury is a technology company that produces component modules and subsystems for the aerospace and defense industries.

For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is this Case About: Mercury Systems, Inc. (MRCY) Misled Investors Regarding its Business Prospects

According to the complaint, during the class period, Mercury Systems, Inc. misled investors regarding its finances. Specifically, defendants failed to disclose that: (a) Mercury’s serial acquirer strategy was not working and the Company was using improper revenue recognition practices such as changing to long-term contracts to mask deteriorating organic growth; (b) the acquisition of Physical Optics Corporation (“POC”) would cause POC to lose its small business accreditation, which would prevent POC from winning contracts that made up a large portion of its historical business; and (c) Mercury’s 1MPACT initiative to increase margins was not working and was in fact cutting into margins.

Plaintiff alleges that a short seller report issued by Glasshouse Research on July 26, 2022, revealed that: (i) Mercury overstated organic growth; (ii) the Acquisition had been a “disaster” which was utilized to obscure Mercury’s financial results; (iii) 1MPACT was a failure; and (iv) Mercury’s management prematurely recognized revenue on significant projects to artificially boost both revenue and earnings unsustainably which also caused the Company’s working capital and unbilled receivables to balloon far beyond industry norms. The Glasshouse Report attributed this premature revenue recognition to Mercury’s executives, noting that management “juice[d] the numbers in their favor” in order to meet revenue and adjusted EBITDA targets, on which the executives’ compensation was based. On this news, the Company's share price fell $4.87 per share, from $62.13 per share on July 25, 2022, to $57.26 per share on July 26, 2022.

Then, on May 2, 2023, Mercury announced weak third quarter 2023 earnings and lower margins that caused the Company to slash its full year 2023 guidance. Mercury also disclosed that approximately a dozen of its 300-plus active programs had been negatively affected by higher costs related to labor and supply chain inefficiencies, manufacturing constraints, and inflation. However, the Company continued to downplay the significance of these issues, claiming that these “challenges” were “not unique to Mercury” and that “structurally, our business model and financial outlook are sound.” On this news, the price of the Company’s common stock declined $7.84 per share, or 17.3%, to close at $37.44 per share on May 3, 2023.

Then, on June 23, 2023, Mercury announced that its CEO had abruptly resigned and that the Company’s recent strategic review of acquisition alternatives did not result in the sale of the Company. On this news, Mercury’s share price declined an additional $3.37 per share, or 9.6%, to close at $31.50 per share on June 26, 2023, wiping out billions in market capitalization.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Mercury Systems, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. Plaintiffs must file their lead plaintiff papers by February 12, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Mercury Systems, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:MRCY

Release Summary
Mercury Systems, Inc. (MRCY) misled investors regarding its business prospects.
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. For more information, submi...

ARDT Class Action Reminder: Stockholders Who Lost Money Investing in Ardent Health, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbins LLP is Investigating...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the NuScale Power Corporation Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired NuScale Power Corporation (NYSE: SMR) Class A shares between May 13, 2025 and November 6, 2025. NuScale is a nuclear technology company focused on scalable, modular reactors. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that...
Back to Newsroom